文献速递生殖医学

一步法复苏玻璃化囊胚改善临床结局:3167例移植回顾性分析

Improved clinical outcomes with one-step warming of vitrified blastocysts: a retrospective analysis of 3167 transfers.
PubMed 文献 · Reprod Biomed Online · 2026-02-04

该回顾性分析纳入3167个玻璃化囊胚复苏周期,比较一步法(n=1750)与常规多步法(n=1417)的复苏后存活、妊娠及新生儿结局。一步法组β-hCG阳性率、临床妊娠率、持续妊娠率和活产率均显著更高(均P<0.001),新生儿结局相当,提示一步法安全有效且可简化实验室流程。

要点

  • 一步法复苏组活产率63.7% vs 多步法57.0%,差异显著(P<0.001)
  • 两组的复苏后存活率均超过99%,新生儿结局相当
  • 年龄<35岁及PGT-A周期中一步法优势更明显

核心结论

  • 一步法复苏是常规多步法安全有效的替代方案,可改善临床结局并简化实验室流程。

研究设计与样本

  • 回顾性分析纳入3167个玻璃化囊胚复苏周期,一步法组1750例,常规多步法组1417例。

主要发现

  • 两组复苏后存活率均超过99%,多步法组早期(0-2 h)再扩张率更高,但4 h时一步法组总队列扩张更优。
  • 总队列中一步法组β-hCG阳性率77.7% vs 73.5%、临床妊娠率72.1% vs 67.2%、持续妊娠率66.5% vs 61.2%、活产率63.7% vs 57.0%,均P<0.001。
  • 年龄<35岁患者中,一步法组持续妊娠率68.9% vs 64.0%(P=0.04)、活产率66.8% vs 59.6%(P=0.003)显著更高。
  • 同年龄组PGT-A周期中,一步法组临床妊娠率78.8% vs 71.9%(P=0.019)显著改善。
  • 各年龄组活产率一步法组数值上更高但差异未达显著,两组新生儿结局相当。

关键数值与推荐

  • 总队列一步法组β-hCG阳性率77.7% vs 73.5%(P<0.001)。
  • 总队列一步法组临床妊娠率72.1% vs 67.2%(P<0.001)。
  • 总队列一步法组持续妊娠率66.5% vs 61.2%(P<0.001)。
  • 总队列一步法组活产率63.7% vs 57.0%(P<0.001)。
  • 年龄<35岁一步法组活产率66.8% vs 59.6%(P=0.003)。

临床怎么用

  • 生殖中心可考虑将一步法复苏作为玻璃化囊胚的常规复苏方案,以简化流程并可能改善妊娠结局。
  • 对年龄<35岁及行PGT-A的患者,一步法复苏的临床获益更明显。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does a one-step warming protocol for vitrified blastocysts improve post-warming recovery, clinical outcomes and neonatal safety compared with a conventional multi-step warming method? DESIGN: A retrospective analysis of 3167 vitrified blastocyst warming cycles compared outcomes between a one-step protocol (n = 1750) and a conventional multi-step protocol (n = 1417). Key outcomes included post-warming survival and re-expansion, biochemical and clinical pregnancy rates, ongoing pregnancy rate, live birth rate, neonatal parameters (gestational age, birth weight) and miscarriage rate. Subgroup analyses were performed in Society for Assisted Reproductive Technology age groups and preimplantation genetic testing for aneuploidy (PGT-A) cycles. RESULTS: Post-warming survival exceeded 99% in both groups. Early re-expansion (0-2 h) was higher for the multi-step warming protocol, but by 4 h, the one-step warming protocol showed better expansion in the total cohort. The one-step warming protocol achieved significantly higher rates of β-human chorionic gonadotrophin positivity (77.7% versus 73.5%), clinical pregnancy (72.1% versus 67.2%), ongoing pregnancy (66.5% versus 61.2%) and live birth (63.7% versus 57.0%; all P < 0.001) in the total cohort. In patients aged <35 years, ongoing pregnancy and live birth rates were significantly higher with the one-step warming protocol (68.9% versus 64.0%, P = 0.04; 66.8% versus 59.6%, P = 0.003). In the same age group with PGT-A, clinical pregnancy improved significantly (78.8% versus 71.9%; P = 0.019). Live births across age groups were numerically higher with the one-step warming protocol, although the differences did not achieve significance, and neonatal outcomes were comparable between protocols. CONCLUSIONS: One-step warming is a safe and effective alternative to conventional multi-step warming. It improves clinical outcomes, particularly in younger patients and euploid embryo transfers, while maintaining neonatal safety and streamlining laboratory workflows.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Yelke HK, Çetinkaya CP, Aygün TM, et al. Improved clinical outcomes with one-step warming of vitrified blastocysts: a retrospective analysis of 3167 transfers. Reprod Biomed Online. 2026. PMID: 42184780. doi:10.1016/j.rbmo.2026.105543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。